Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis.
about
CFTR Modulators: Shedding Light on Precision Medicine for Cystic FibrosisRibosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression DefectBarriers to inhaled gene therapy of obstructive lung diseases: A reviewAn overview of international literature from cystic fibrosis registries. Part 5: Update 2012-2015 on lung disease.Loss of SLC9A3 decreases CFTR protein and causes obstructed azoospermia in mice.Long Non-coding RNA BGas Regulates the Cystic Fibrosis Transmembrane Conductance RegulatorUsing Drugs to Probe the Variability of Trans-Epithelial Airway Resistance.Reverse Pathway Genetic Approach Identifies Epistasis in Autism Spectrum Disorders.In silico search for modifier genes associated with pancreatic and liver disease in Cystic FibrosisEarly Lung Function Decline in Cystic Fibrosis: Can Registry Data Explain Divergent Phenotypes?Novel variation at chr11p13 associated with cystic fibrosis lung disease severity.Genome sequencing in a case of Niemann-Pick type CSingle-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis.Retinoic acid catabolizing enzyme CYP26C1 is a genetic modifier in SHOX deficiency.DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis.Airway Mucosal Host Defense is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity.Glutamine transporters in mammalian cells and their functions in physiology and cancer.Ets homologous factor (EHF) has critical roles in epithelial dysfunction in airway disease.Restoration of R117H CFTR folding and function in human airway cells through combination treatment with VX-809 and VX-770Computation of ancestry scores with mixed families and unrelated individuals.Are genetic polymorphisms in the renin-angiotensin-aldosterone system associated with essential hypertension? Evidence from genome-wide association studies.Impact of gene editing on the study of cystic fibrosis.Pharmacogenetics of cystic fibrosis treatment.Exploiting the potential of next-generation sequencing in genomic medicine.Clinical approach to the diagnosis and treatment of cystic fibrosis and CFTR-related disorders.From Peas to Disease: Modifier Genes, Network Resilience, and the Genetics of Health.The Sweat Metabolome of Screen-Positive Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics.IL8 gene as modifier of cystic fibrosis: unraveling the factors which influence clinical variability.Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severityIncreased Expression of Plasma-Induced ABCC1 mRNA in Cystic Fibrosis.Goblet Cell Hyperplasia Requires High Bicarbonate Transport To Support Mucin Release.Regulatory dynamics of 11p13 suggest a role for EHF in modifying CF lung disease severity.The population genetics of human disease: The case of recessive, lethal mutations.Lessons learned from the search for genes responsible for rare Mendelian disorders.Recent progress in translational cystic fibrosis research using precision medicine strategies.Correlations between cystic fibrosis genotype and sinus disease severity in chronic rhinosinusitis.SLC6A14 Is a Genetic Modifier of Cystic Fibrosis That Regulates Pseudomonas aeruginosa Attachment to Human Bronchial Epithelial Cells.SLC9A3 Protein Is Critical for Acrosomal Formation in Postmeiotic Male Germ Cells.TGFβ as a therapeutic target in cystic fibrosis.
P2860
Q28073996-C301CFAD-1856-4CD9-941F-B3EC854E99CFQ28551966-9A378389-4CCF-4448-89E6-7FCE845FB593Q29248141-81427158-31FE-4789-88A7-6FC6BF04A69DQ30244524-A3DC3362-ECD6-4D38-A672-3F5E8AA83D80Q33585358-DD05A550-E45D-4B32-A993-7BAF0DD1DF87Q34534598-B4B03372-7963-455F-B7EF-2DC7B5586CE1Q35939601-10A8FEBB-ECF4-4626-88B6-0681CAB7B624Q36246158-477FFEF0-5857-481F-B281-1E86725047E3Q36322032-8AC605A7-1795-4D4F-B78D-5E9B04478C74Q36371926-16F72C6C-43EA-4058-B3DF-A87E459C2320Q37072396-986DDB9C-B27E-4AAF-804B-3D9328A180D1Q37416674-3F8BF9D3-D385-416F-84AA-6513B0E494C7Q37469191-7F90B557-BB19-494F-921B-2341A34E0773Q37514812-682495D5-F9A1-4F6D-A588-59E3F19E04EFQ37642982-6273B52C-F029-47D6-9105-B2FCB8341552Q38602344-E54B5956-3271-4D1C-BBE0-2F6D1309EF24Q38685207-1A9A8E76-1232-4772-9098-9D09F0FE6147Q38705271-923CEEAF-221E-498E-83F9-25C2C29F7D43Q38758711-55834373-37BD-4B83-AAE4-19F7896D4E60Q38815316-E5657BDE-7770-4053-89F8-CBDEA3B97F3DQ38829205-F4F19177-9399-433F-8C87-EA0DE8EADD92Q38871526-6B37ECC9-BC34-46E9-BFCE-42521ACADC6BQ38918082-00D7E159-30D6-471D-9082-BE40550663CBQ38940833-0B158A60-0080-4709-BB91-AB131F7284E1Q38960863-EF21AC1D-7AAB-46C3-B106-AB86CCF3ACD7Q39310748-DB47EDA0-E7BE-49DC-A0C2-0B4C49E94BD2Q40075178-90FB13BB-8F20-4495-BA3D-B071B70CB070Q40341616-E3E775DB-1EF2-4EA9-ADA2-67523759A493Q40664954-E6C0EA75-F7AE-458B-BB91-7C5A74FEED13Q41533194-A2311EF7-CDBE-4704-8608-52ED63FF2C2AQ41574129-18DC1546-67ED-4F4F-AC7E-FE31DE8170B3Q41587755-D2B3743A-6461-4D3F-9EFD-9B42BC2AB032Q41629928-05C1E3AA-5060-48CA-A7EA-EC7F9A70C873Q42366136-70B605FF-27AA-45EC-9CF8-32638DBAA708Q42416155-86A377B3-3C68-4576-8A1B-CD2C57ACE99FQ45872872-810834D5-3CBA-414A-B544-6986EA6CFA54Q46598983-83429F02-00F2-4DEC-B019-EFEB01EBAD6AQ47141716-9FA07691-904F-4BB3-ADFA-4495FCF858CCQ47235140-CB315A73-DDBB-493C-A3F7-33F452A4B717Q47822059-3C3B8391-60BD-424E-A76F-93A000DB3B77
P2860
Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Genome-wide association meta-a ...... e severity in cystic fibrosis.
@ast
Genome-wide association meta-a ...... e severity in cystic fibrosis.
@en
type
label
Genome-wide association meta-a ...... e severity in cystic fibrosis.
@ast
Genome-wide association meta-a ...... e severity in cystic fibrosis.
@en
prefLabel
Genome-wide association meta-a ...... e severity in cystic fibrosis.
@ast
Genome-wide association meta-a ...... e severity in cystic fibrosis.
@en
P2093
P2860
P50
P356
P1476
Genome-wide association meta-a ...... e severity in cystic fibrosis.
@en
P2093
Annick Clement
Anthony T Dang
Arianna Franca
Frank J Accurso
Fred A Wright
Garry R Cutting
Jaclyn R Stonebraker
P2860
P2888
P356
10.1038/NCOMMS9382
P407
P577
2015-09-29T00:00:00Z
P5875
P6179
1023757952